An Emergency Department is considering an artificial intelligence tool that flags possible abnormalities on chest radiographs. The supplier reports excellent performance from a large overseas dataset and says the tool is already used in a private radiology network. No local Emergency Department validation has been performed. The tool is not integrated with the local electronic patient record or PACS, and there is no agreed process for acting on discrepant results when clinician interpretation and the algorithm disagree.

According to RCEM’s position statement on artificial intelligence, what is the most appropriate next step before clinical implementation? Select only one best single option.